Stratistics MRC에 따르면 세계의 혈당 검사용 스트립 포장 시장은 2025년 24억 달러를 차지하고 예측 기간 동안 CAGR 8.6%로 성장해 2032년까지 44억 달러에 이를 것으로 예측됩니다.
혈당 검사용 스트립 포장은 혈당의 모니터링에 사용되는 검사용 스트립의 무결성과 기능성을 유지하기 위해 설계된 특수 봉입물을 가리킵니다. 일반적으로 튼튼하고 내습성이 있는 소재로 만들어진 포장은 무균성을 유지하면서, 유저가 간단하게 액세스할 수 있게 되어 있습니다. 선진적인 디자인에는 사용의 용이성과 안전성을 높이기 위해서, 리시러블 클로저, 개별 컴파트먼트, 탬퍼 에비던트 씰등의 기능이 짜넣어지고 있습니다.
유니세프의 타겟 제품 프로파일 1판에 따르면, 저자원 환경에서는 진단실험실에 대한 액세스가 여전히 중요한 과제가 되고 있습니다.
재택 검사 및 원격 환자 모니터링 증가
당뇨병의 유병률이 세계적으로 상승함에 따라, 혈당 관리를 위한 편리하고 이용하기 쉬운 솔루션이 우선하게 되어 있습니다. 비용을 절감하고 질병 관리를 개선할 수 있으며, 디지털 헬스 기술의 진보로 검사용 스트립의 패키징과 스마트 모니터링 장비의 원활한 통합이 가능해져 사용자 경험이 향상되었습니다.
복잡한 제조 및 공급망 요구사항
제조자는 규제 기준을 준수하고 포장 재료가 검사용 스트립의 무결성을 손상시키지 않도록 해야 합니다. 또한 내습성 필름이나 변조 방지 씰 등의 특수 재료를 조달하는 것은 제조 비용을 증가시킵니다.
생분해성 또는 재활용 가능한 소재에 대한 주목의 향상
환경에 대한 관심이 높아짐에 따라 건강 관리 산업은 플라스틱 폐기물을 줄이기 위해 지속 가능한 패키징 솔루션으로 전환하고 있습니다. 또한 규제기관도 환경에 배려한 포장방법의 채용을 장려하고 있으며, 기업은 혁신적인 소재에 대한 투자를 촉진하고 있습니다.
지속 포도당 모니터링(CGM) 장비를 통한 대체
CGM 기술은 자주 손가락을 찔러서 검사하지 않고 실시간 포도당 추적을 제공하며, 기존의 검사용 스트립에 대한 의존도를 줄입니다. 혈당 검사용 스트립에 대한 수요는 감소할 수 있습니다.
COVID-19 팬데믹은 혈당 검사용 스트립 포장 시장에 다양한 영향을 주었으며 공급망과 소비자 행동 모두에 영향을 주었습니다. 병원의 진찰을 최소화하기 위해 재택 검사를 우선해, 검사용 스트립과 신뢰성이 높은 포장 솔루션에 대한 수요가 높아졌습니다.
예측 기간 동안 바이알 및 튜브 부문이 최대가 될 전망
바이알 및 튜브 부문은 검사용 스트립 보관에 널리 사용되므로 예측 기간 동안 최대 시장 점유율을 차지할 것으로 예측됩니다.
예측 기간 동안 알루미늄 부문이 가장 높은 CAGR이 예상됩니다.
예측 기간 동안 알루미늄 부문은 뛰어난 장벽 특성과 지속가능성의 이점으로 인해 가장 높은 성장률을 나타낼 것으로 예측됩니다. 환경 친화적인 건강 관리 솔루션에 대한 주목을 받고 있으며 제조업체에게 매력적인 옵션이되었습니다.
예측 기간 동안 북미는 당뇨병 이환율이 높고 강력한 건강 관리 인프라에 견인되어 최대 시장 점유율을 차지할 것으로 예측됩니다. 당뇨병 관리 및 예방 건강 관리에 대한 소비자의 의식은 신뢰할 수있는 검사용 스트립 포장 솔루션 수요를 촉진하고 있습니다.
예측기간 중 아시아태평양은 헬스케어 투자 증가, 당뇨병 환자 증가, 의료기기에 대한 접근 확대를 배경으로 가장 높은 CAGR을 나타낼 것으로 예측됩니다.
According to Stratistics MRC, the Global Blood Glucose Test Strip Packaging Market is accounted for $2.4 billion in 2025 and is expected to reach $4.4 billion by 2032 growing at a CAGR of 8.6% during the forecast period. Blood glucose test strip packaging refers to specialized containment designed to preserve the integrity and functionality of test strips used for monitoring blood sugar levels. These packages protect the strips from moisture, contamination, and external damage, ensuring accurate readings. Typically made from durable, moisture-resistant materials, the packaging maintains sterility while allowing easy access for users. Advanced designs incorporate features like resealable closures, individual compartments, and tamper-evident seals to enhance usability and safety.
According to the UNICEF target product profile, 1st edition, access to diagnostic laboratories remains a key challenge in low-resource settings. Point-of-care diagnostic tests enable healthcare workers to provide more rapid and effective care.
Increased home-based testing and remote patient monitoring
As diabetes prevalence rises globally, individuals are prioritizing convenient and accessible solutions for blood glucose management. Home-based testing allows patients to monitor their glucose levels without frequent hospital visits, reducing healthcare costs and improving disease management. Additionally, advancements in digital health technologies are enabling seamless integration of test strip packaging with smart monitoring devices, enhancing user experience.
Complex manufacturing and supply chain requirements
Manufacturers must adhere to regulatory standards, ensuring that packaging materials do not compromise the integrity of test strips. Additionally, sourcing specialized materials such as moisture-resistant films and tamper-evident seals adds to production costs. Supply chain disruptions, including raw material shortages and transportation challenges, can impact timely distribution, affecting market growth.
Growing focus on biodegradable or recyclable materials
As environmental concerns rise, healthcare industries are shifting toward sustainable packaging solutions to reduce plastic waste. Manufacturers are exploring eco-friendly alternatives such as biodegradable films and recyclable containers to align with global sustainability goals. Regulatory bodies are also encouraging the adoption of green packaging practices, prompting companies to invest in innovative materials. Additionally, consumer awareness regarding environmental impact is influencing purchasing decisions, driving demand for sustainable healthcare products.
Substitution by continuous glucose monitoring (CGM) devices
CGM technology offers real-time glucose tracking without the need for frequent finger-prick tests, reducing reliance on traditional test strips. As CGM adoption increases, particularly among individuals with advanced diabetes management needs, demand for blood glucose test strips may decline. Additionally, healthcare providers are advocating for CGM devices due to their ability to provide comprehensive glucose trend analysis, improving treatment outcomes.
The COVID-19 pandemic had a mixed impact on the blood glucose test strip packaging market, influencing both supply chains and consumer behavior. While initial disruptions in manufacturing and logistics led to temporary shortages, the crisis also heightened awareness of diabetes management. Patients prioritized home-based testing to minimize hospital visits, increasing demand for test strips and reliable packaging solutions. The shift toward telemedicine and remote healthcare consultations further supported market growth, as individuals sought convenient monitoring tools.
The vials/tubes segment is expected to be the largest during the forecast period
The vials/tubes segment is expected to account for the largest market share during the forecast period due to its widespread use in test strip storage. Vials and tubes provide superior protection against moisture, contamination, and physical damage, ensuring the accuracy of blood glucose readings. Their resealable design enhances convenience, allowing users to access test strips while maintaining sterility.
The aluminum segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the aluminum segment is predicted to witness the highest growth rate driven by its superior barrier properties and sustainability advantages. Aluminum packaging offers excellent moisture resistance, ensuring the longevity of test strips in various environmental conditions. Additionally, its recyclability aligns with the growing focus on eco-friendly healthcare solutions, making it an attractive option for manufacturers. The segment is benefiting from technological advancements in lightweight aluminum packaging, enhancing portability and user convenience.
During the forecast period, the North America region is expected to hold the largest market share driven by high diabetes prevalence and strong healthcare infrastructure. The region has a well-established medical device industry, with leading manufacturers investing in advanced packaging technologies. Additionally, consumer awareness regarding diabetes management and preventive healthcare is fueling demand for reliable test strip packaging solutions.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by rising healthcare investments, increasing diabetes cases, and expanding access to medical devices. Countries such as China, India, and Japan are experiencing a surge in demand for blood glucose monitoring tools, driving packaging innovations. Government initiatives promoting diabetes awareness and early diagnosis are further supporting market expansion.
Key players in the market
Some of the key players in Blood Glucose Test Strip Packaging Market include Abbott, ACON Laboratories Inc., AgaMatrix, Amcor, Aptar CSP Technologies, ARKRAY Inc., Ascensia Diabetes Care, Bionime Corporation, LifeScan IP Holdings LLC, Multisorb, Procurenet Limited, Roche, Rossmax International Ltd, Sanner, Shijiazhuang Xinfuda Medical Packaging Co., Ltd., Trividia Health Inc., Wisesorbent Technology, and YuHuan KangJia.
In November 2024, Ascensia Diabetes Care, in collaboration with Fitterfly Healthtech, launched a 21-day Diabetes Management Program on World Diabetes Day. This initiative offers Ascensia glucometer users personalized support, including diet plans, AI wellness coaching, and expert guidance to simplify diabetes management.
In September 2024, Aptar CSP's N-Sorb Nitrosamine Mitigation Solution was accepted into the US FDA's Emerging Technology Program, addressing concerns related to N-nitrosamine impurities in pharmaceuticals.